BRIOSCHI, MAURA
 Distribuzione geografica
Continente #
EU - Europa 3.457
NA - Nord America 3.004
AS - Asia 980
SA - Sud America 50
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 4
Totale 7.510
Nazione #
US - Stati Uniti d'America 2.980
GB - Regno Unito 1.112
IT - Italia 621
DE - Germania 591
SE - Svezia 468
CN - Cina 437
TR - Turchia 139
KR - Corea 133
RU - Federazione Russa 131
IN - India 122
UA - Ucraina 111
IE - Irlanda 104
EU - Europa 75
FI - Finlandia 73
FR - Francia 68
NL - Olanda 53
PL - Polonia 47
SG - Singapore 47
HK - Hong Kong 44
CO - Colombia 38
GR - Grecia 29
BE - Belgio 19
ID - Indonesia 19
CA - Canada 17
VN - Vietnam 14
BR - Brasile 8
AU - Australia 7
JP - Giappone 7
CH - Svizzera 6
DK - Danimarca 5
HU - Ungheria 4
JM - Giamaica 4
CL - Cile 3
IL - Israele 3
MX - Messico 3
NZ - Nuova Zelanda 3
PH - Filippine 3
RO - Romania 3
AT - Austria 2
CI - Costa d'Avorio 2
ES - Italia 2
IR - Iran 2
MY - Malesia 2
NO - Norvegia 2
PT - Portogallo 2
UZ - Uzbekistan 2
BD - Bangladesh 1
BY - Bielorussia 1
EC - Ecuador 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
IS - Islanda 1
JO - Giordania 1
MK - Macedonia 1
NP - Nepal 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
Totale 7.580
Città #
Southend 1.032
Boise 651
Chandler 330
Seattle 172
Milan 170
Princeton 147
Ashburn 145
Ann Arbor 131
Wilmington 129
Beijing 124
Hanover 120
Dublin 104
Munich 102
Jacksonville 89
Frankfurt am Main 68
Redmond 68
Dearborn 66
Fairfield 64
Somerville 60
Nanjing 55
Mountain View 54
Woodbridge 48
Warsaw 46
Hong Kong 43
Seoul 43
Cottonwood 41
Sakarya 41
Serra 41
Andover 40
Bogotá 38
Garden Valley 38
Houston 37
Bengaluru 34
Berlin 34
Boardman 34
Jerome 34
Des Moines 33
Athens 29
Lewiston 28
Jinan 26
Orofino 26
Payette 26
Falls Church 25
Eitensheim 23
Cambridge 22
Phoenix 22
Shenyang 22
Helsinki 20
Singapore 20
Brussels 19
Guangzhou 19
Washington 17
Hamburg 16
Nanchang 16
Shanghai 16
Bitonto 13
New York 13
Changsha 12
Haikou 11
Jiaxing 11
Nürnberg 10
Hebei 9
Ningbo 9
Toronto 9
Auburn Hills 8
Bühl 8
Centro 8
Kunming 8
Lanzhou 8
Norwalk 8
San Diego 8
San Jose 8
Sunnyvale 8
Bornova 7
Kent 7
Mcallen 7
Saint Petersburg 7
Amsterdam 6
Delhi 6
Grafing 6
Redwood City 6
Fuzhou 5
Kiez 5
Pune 5
Roxbury 5
São Paulo 5
Dong Ket 4
Kingston 4
Lowell 4
Nordman 4
Tianjin 4
Tokyo 4
Turin 4
Vancouver 4
Zhengzhou 4
Budapest 3
Canberra 3
Columbia 3
Costa Mesa 3
London 3
Totale 5.195
Nome #
Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall 1.061
Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment 419
Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure 177
Data for proteomic analysis of human monocyte-derived macrophages 165
AT1 receptor blockade provides end-organ protection in stroke-prone rats by anti-inflammatory effects 159
Analysis of rosuvatatin by imaging mass spectrometry 154
S 35171 exerts protective effects in stroke-prone rats by preservation of mitochondrial function 150
Optimized protocol for the extraction of proteins from the human mitral valve 148
BDNFVal66met polymorphism : a potential bridge between depression and thrombosis 147
S 35171 exerts protective effects in spontaneously hypertensive stroke-prone rats by preserving mitochondrial function 146
Terutroban, a TP receptor antagonist, increased survival il stroke-prone rats by preserving systemic inflammation and endothelial dysfunction. Comparison with aspirin and rosuvastatin 143
Peroxisome Proliferator-Activated Receptor α Agonism Prevents Renal Damage and the Oxidative Stress and Inflammatory Processes Affecting the Brains of Stroke-Prone Rats 140
Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts 138
Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme 137
Effect of S18886, a thromboxane A2 receptor antagonist, on the occurrence of spontaneous brain damage 137
Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro 136
Increased activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin pre-treatment 131
Proteome of endothelial cell-derived procoagulant microparticles 130
Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats 130
Terutroban, a Thromboxane/Prostaglandin Endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction. Comparison with aspirin and rosuvastatin 128
Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cells 126
Increased activation of NF-KB and ERK1/2 after permanent focal ischemia is abolished by simvastatin pre-treatment 126
Nonenzymatically glycated lipoprotein ApoA-I in plasma of diabetic and nephropathic patients 121
Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/antiprotease imbalance in favor of the serpin alpha1-antichymotrypsin 121
Acute high-altitude exposure reduces lung diffusion: data from the HIGHCARE Alps project 121
Mitochondrial reactive oxygen species : a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells 120
Proteome of platelets in patients with coronary artery disease 120
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 119
N-acetyl-cysteine regenerates albumin cys34 by a thiol-disulfide breaking mechanism: An explanation of its extracellular antioxidant activity 119
Vascular fibrosis in stroke-prone rats (SHRSP) is prevented by drugs active on inflammatory pathways 118
On the search for glycated lipoprotein ApoA-I in the plasma of diabetic and nephropathic patients 115
Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure 114
A mass spectrometry-based workflow for the proteomic analysis of in vitro cultured cell subsets isolated by means of laser capture microdissection 114
S-Thiolation Targets Albumin in Heart Failure 111
Proteome of endothelial cell-derived procoagulant microparticles 101
Protease-activated receptors 1 and 2 activation induces tissue factor through mitochondrial reactive oxygen species 101
Transglutaminase 2 modulates efferocytosis in human monocyte-derived macrophages 100
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 95
Human macrophages spontaneously differentiated in vitro are heterogeneous and show different proteomic profile 93
Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts 91
Tissue factor induction by protease-activated receptor-1 requires intact caveolin-enriched membrane microdomains in human endothelial cells 91
Phenotypic profile of lipid-enriched macrophages spontaneously differentiated from blood-derived monocytes 91
Distinct phenotypes co-exist in the same culture of human monocyte-derived macrophages 91
Proteomic analysis of atherosclerotic plaque 90
Oxidized proteins in plasma of patients with heart failure : role in endothelial damage 89
Neurohormonal activation is associated with increased levels of plasma MMP-2 in human heart failure 86
Immature circulating SP-B, bound to HDL, represents an early sign of smoke-induced pathophysiological alterations 84
Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment 82
Plasma immature form of surfactant protein type B correlates with prognosis in patients with chronic heart failure : a pilot single-center prospective study 80
Proteomic analysis of human low density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme 78
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 78
Plasma oxidized proteins in human heart failure : role in endothelial dysfunction 77
Acrylate-based materials for heart valve scaffold engineering 77
Culture Into Perfusion-Assisted Bioreactor Promotes Valve-Like Tissue Maturation of Recellularized Pericardial Membrane 76
Human macrophages spontaneously differentiated from blood monocytes are heterogeneous and show distinct proteome profiling 68
Towards the standardization of mitochondrial proteomics : the Italian Mitochondrial Human Proteome Project Initiative 68
Proteome of endothelial cell-derived procoagulant microparticles 67
Immature surfactant protein-B impairs the antioxidant capacity of HDL 66
Multiplexed MRM-Based Proteomics Identified Multiple Biomarkers of Disease Severity in Human Heart Failure 64
Proteomic analysis of endothelial cell secretome: a means of studying the pleiotropic effects of Hmg-CoA reductase inhibitors 56
La proteomica in campo cardiovascolare: sfide ed opportunità per la cardiologia del futuro 52
Proteomics of tissue factor silencing in cardiomyocytic cells reveals a new role for this coagulation factor in splicing machinery control 52
N-Acetylcysteine Regenerates In Vivo Mercaptoalbumin 25
Normal human mitral valve proteome : A preliminary investigation by gel-based and gel-free proteomic approaches 11
Totale 8.021
Categoria #
all - tutte 18.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201926 0 0 0 0 0 0 0 0 0 0 0 26
2019/2020645 98 22 25 34 31 73 91 29 66 122 34 20
2020/2021714 17 74 65 17 90 47 35 45 58 42 187 37
2021/2022919 99 48 34 46 68 122 91 53 55 74 64 165
2022/20231.144 219 141 104 118 101 194 30 77 96 21 34 9
2023/2024518 25 34 40 56 150 63 13 51 6 38 40 2
Totale 8.021